digiMedical Solutions, Inc. Announces Corporate Overview Report on Yahoo! Finance Featuring Proprietary Microsoft-Based Prescription Technology

Report Highlights Recent Analyst Coverage With PPS Recommendation of $0.30 or Higher vs. Recent $0.08

COLLEYVILLE, TX--(Marketwire - March 18, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced a new Corporate Overview Report available on Yahoo! Finance. The Report features digiMedical's proprietary, Microsoft-based digital prescription handling technology, brick and mortar pharmacy locations and recent Board of Directors expansion in preparation for a move to the OTCBB. The Company has grown from a start-up in 2005 to forecasting 2008 revenues of $10 million. The report also highlights the first analyst review on the company with a recommendation of $0.30 or higher.

To request a copy of the report, please go to http://finance.yahoo.com/q?s=dgms.pk and click "Download Annual Report" under the Company's stock chart.

The report on Yahoo! Finance has been provided as a service by PrecisionIR (www.precisionir.com). PrecisionIR is well known for its Vcall service, providing corporate earnings calls in addition to other webcasts and interactive webinar services.

Recent Analyst Report Coverage with Recommendation of $0.30 or Higher vs. Recent $0.08

Micros Report has initiated research coverage of digiMedical Solutions, and has issued a report reviewing the Company's historical operations and 2008 business plan. digiMedical has created a new breed of pharmacy, integrating its own suite of proprietary software handling prescriptions digitally and securely from the physician's office into company owned brick and mortar pharmacies.

According to the report, prescription drug sales and utilization are growing rapidly and the market is expected to grow 148% by 2016 to nearly $500 billion in sales.

Michael Willingham, Micros Report Director of Research, authored the report which includes a Fair Value Target price for DGMS of $0.30. This valuation is based on company characteristics that give it the potential to trade in a range as high as $0.89 vs. the recent close of $0.08. In the report, Mr. Willingham stated, "digiMedical's proprietary technology solution positions the company to profit from both the traditional existing pharmacy market space and the future of digital prescription fulfillment."

The report is available at http://www.digimedical.com/news/news.aspx under "Featured Presentation." Interested parties may also access the report by going to the www.MicrosReport.com homepage or by emailing ir@digimedical.com and requesting a copy.

Corporate Email Updates

To be added to digiMedical's e-mail database to receive company updates, or for more information on the Company, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.™ (www.digiMedical.com)

digiMedical Solutions, Inc.™ is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's continued growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, acquisition of independent pharmacy chains and the sale of select territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions™ currently owns and operates five pharmacies throughout Texas and Florida and is a Microsoft Independent Software Vendor (ISV). digiMedical Solutions™ unique business model connects physicians, patients and pharmacies with next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 ir@digimedical.com